Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

The role of dopamine in the mechanism of action of antidepressant drugs.

D'Aquila PS, Collu M, Gessa GL, Serra G.

Eur J Pharmacol. 2000 Sep 29;405(1-3):365-73. Review.

PMID:
11033341
2.

Dopamine and melatonin in the nucleus accumbens may be implicated in the mode of action of antidepressant drugs.

Durlach-Misteli C, Van Ree JM.

Eur J Pharmacol. 1992 Jun 24;217(1):15-21.

PMID:
1397023
3.
4.

Dopamine D3 receptor antisense oligodeoxynucleotide potentiates imipramine-induced dopaminergic behavioural supersensitivity.

D'Aquila PS, Panin F, Castelli MP, Serra G.

Behav Pharmacol. 2006 Mar;17(2):101-6.

PMID:
16495718
5.

The mesolimbic dopamine system as a target for rapid antidepressant action.

Willner P.

Int Clin Psychopharmacol. 1997 Jul;12 Suppl 3:S7-14. Review.

PMID:
9347387
6.

Brain noradrenaline and the mechanisms of action of antidepressant drugs.

Svensson TH.

Acta Psychiatr Scand Suppl. 2000;402:18-27. Review.

PMID:
10901155
7.

Dopamine D2-like receptors and the antidepressant response.

Gershon AA, Vishne T, Grunhaus L.

Biol Psychiatry. 2007 Jan 15;61(2):145-53. Epub 2006 Aug 24. Review.

PMID:
16934770
9.

Nicotine potentiates imipramine-induced effects on catecholamine metabolism: possible relation to antidepressant activity.

Antkiewicz-Michaluk L, Michaluk J, Romańska I, Popik P, Krawczyk M, Nalepa I, Vetulani J.

Pharmacol Rep. 2006 Nov-Dec;58(6):836-45.

10.

Reversal of antidepressant-induced dopaminergic behavioural supersensitivity after long-term chronic imipramine withdrawal.

D'Aquila PS, Peana AT, Panin F, Grixoni C, Cossu M, Serra G.

Eur J Pharmacol. 2003 Jan 1;458(1-2):129-34.

PMID:
12498916
11.

Modulation of synaptic plasticity by stress and antidepressants.

Popoli M, Gennarelli M, Racagni G.

Bipolar Disord. 2002 Jun;4(3):166-82. Review.

PMID:
12180272
12.

Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.

Ogren SO, Kuteeva E, Hökfelt T, Kehr J.

CNS Drugs. 2006;20(8):633-54. Review.

PMID:
16863269
13.

The mode of action of sulpiride as an atypical antidepressant agent.

Jenner P, Marsden CD.

Adv Biochem Psychopharmacol. 1982;32:85-103. Review.

PMID:
7046370
14.

[Mechanism of action of new generation antidepressants under development in Japan: focusing on dopamine neurotransmission].

Nakayama K.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2009 Jun;29(3):99-108. Review. Japanese.

PMID:
19663259
15.

[Efficacy of atypical antipsychotics in depressive syndromes].

Quintin P, Thomas P.

Encephale. 2004 Nov-Dec;30(6):583-9. Review. French.

PMID:
15738862
16.

Modulation of dopamine transmission by 5HT2C and 5HT3 receptors: a role in the antidepressant response.

Dremencov E, Weizmann Y, Kinor N, Gispan-Herman I, Yadid G.

Curr Drug Targets. 2006 Feb;7(2):165-75. Review.

PMID:
16475958
17.

Serotonin-dopamine interaction as a focus of novel antidepressant drugs.

Esposito E.

Curr Drug Targets. 2006 Feb;7(2):177-85. Review.

PMID:
16475959
18.

Modulation of brain dopamine transmission by sex steroids.

Di Paolo T.

Rev Neurosci. 1994 Jan-Mar;5(1):27-41. Review.

PMID:
8019704
19.

Second messenger-regulated protein kinases in the brain: their functional role and the action of antidepressant drugs.

Popoli M, Brunello N, Perez J, Racagni G.

J Neurochem. 2000 Jan;74(1):21-33. Review.

20.

The serotonin-dopamine interaction is critical for fast-onset action of antidepressant treatment: in vivo studies in an animal model of depression.

Dremencov E, Gispan-Herman I, Rosenstein M, Mendelman A, Overstreet DH, Zohar J, Yadid G.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):141-7.

PMID:
14687868

Supplemental Content

Support Center